Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustained virological response (SVR) reduces even more the risk. Presentation of case Liver resection for small HCC was performed in cleared HCV infection non-cirrhotic 62-year-old man. Methacronous oligometastatic recurrences in intolerant to Nexavar® side-effects patient, were treated by multiple innovative microinvasive approaches: bilateral laparoscopic adrenalectomy, thoracic wall resection, laparoscopic sacrum cryoablation combined with hadron-therapy. Discussion Therapies allowed the patient to lead 6 years satisfying QoL with only a small residual presacral disease stable at 8 months. Conclusion Microinvasive surgery may be a valid resource of therapy in indolent HCC limited distant recurrences.

Case-report. Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver. Surgical therapy / Brozzetti, Stefania; Bini, Simone; Fazzi, Katia; Chiarella, Leonardo Luca; Ceccarossi, Virginia; De Lucia, Chiara; De Toma, Giorgio. - In: INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. - ISSN 2210-2612. - 47:(2018), pp. 19-21. [10.1016/j.ijscr.2018.04.013]

Case-report. Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver. Surgical therapy

Brozzetti, Stefania
;
Bini, Simone;Fazzi, Katia;Chiarella, Leonardo Luca;Ceccarossi, Virginia;De Lucia, Chiara;De Toma, Giorgio
2018

Abstract

Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustained virological response (SVR) reduces even more the risk. Presentation of case Liver resection for small HCC was performed in cleared HCV infection non-cirrhotic 62-year-old man. Methacronous oligometastatic recurrences in intolerant to Nexavar® side-effects patient, were treated by multiple innovative microinvasive approaches: bilateral laparoscopic adrenalectomy, thoracic wall resection, laparoscopic sacrum cryoablation combined with hadron-therapy. Discussion Therapies allowed the patient to lead 6 years satisfying QoL with only a small residual presacral disease stable at 8 months. Conclusion Microinvasive surgery may be a valid resource of therapy in indolent HCC limited distant recurrences.
2018
HCC metastase; Mininvasive surgery; Cleared HCV; Hadrontherapy; Laparoscopic malignant adrenalectomy
01 Pubblicazione su rivista::01i Case report
Case-report. Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver. Surgical therapy / Brozzetti, Stefania; Bini, Simone; Fazzi, Katia; Chiarella, Leonardo Luca; Ceccarossi, Virginia; De Lucia, Chiara; De Toma, Giorgio. - In: INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. - ISSN 2210-2612. - 47:(2018), pp. 19-21. [10.1016/j.ijscr.2018.04.013]
File allegati a questo prodotto
File Dimensione Formato  
Brozzetti_Metastases-HCC_2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 642.26 kB
Formato Adobe PDF
642.26 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1275925
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact